Jba Goutamin Tablet
FDA Label NDC 13411-873

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Advanced Pharmaceutical Services, Inc. Dba Affordable Quality Pharmaceuticals for the product Jba Goutamin (NDC 13411-873). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding identity, direction, safe handling warning, other ingredients, product label, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Identity

Dietary Supplement

Direction

Adults – Take 2 tablets twice daily (morning and evening) preferably after a meal.

Safe Handling Warning

GOUTAMIN
NATURAL GOUT SUPPORT*
Promotes Uric Acid Balance*
Enhances Gout Health*
GOUTAMIN supports the alleviation of gout symptoms by:
- Reducing inflammation & promoting joint health*
- Assisting in lowering uric acid levels in the body*
- Supporting healthy kidney function*
- Enhancing joint mobility and flexibility*
- Providing antioxidant benefits to fight oxidative stress*

* These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Other Ingredients

Calcium Stearate, Colloidal Silicon Dioxide, Corn Starch, Ferric Oxides, Hydroxypropyl Methylcellulose, Microcrystalline Cellulose, Polyethylene
Glycol 6000, Polyvinylpyrrolidone (PVP), Sodium Carboxymethylcellulose, Talc, Titanium Dioxide.

Product Label

Image Description (Image 1)

Image Description (Image 1)

* Please review the disclaimer below.